The University of Chicago Header Logo

Connection

John Hart to Time Factors

Back to Details
This is a "connection" page, showing publications John Hart has written about Time Factors.
John Hart
Connection Strength
0.137
Time Factors
  1. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. Clin Gastroenterol Hepatol. 2013 Dec; 11(12):1601-8.e1-4.
    View in: PubMed
    Score: 0.015
  2. Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy. J Clin Gastroenterol. 2013 Jan; 47(1):52-7.
    View in: PubMed
    Score: 0.015
  3. Clinicopathologic features of late-onset veno-occlusive disease/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant. Leuk Lymphoma. 2012 Aug; 53(8):1552-7.
    View in: PubMed
    Score: 0.014
  4. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol. 2008 Jan; 294(1):G208-16.
    View in: PubMed
    Score: 0.010
  5. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy. 2007 Dec; 39(12):1086-91.
    View in: PubMed
    Score: 0.010
  6. Inducible nitric oxide synthase (iNOS) mediates the early increase of blood supply (EIBS) in colon carcinogenesis. FEBS Lett. 2007 Aug 07; 581(20):3857-62.
    View in: PubMed
    Score: 0.010
  7. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology. 2006 Aug; 44(2):489-501.
    View in: PubMed
    Score: 0.010
  8. Improved bioavailability of the mGlu2/3 receptor agonist LY354740 using a prodrug strategy: in vivo pharmacology of LY544344. J Pharmacol Exp Ther. 2006 Feb; 316(2):905-13.
    View in: PubMed
    Score: 0.009
  9. Long-term survival of intestinal allografts induced by costimulation blockade, busulfan and donor bone marrow infusion. Am J Transplant. 2003 Sep; 3(9):1091-8.
    View in: PubMed
    Score: 0.008
  10. Role of 4-1BB in allograft rejection mediated by CD8+ T cells. Am J Transplant. 2003 May; 3(5):543-51.
    View in: PubMed
    Score: 0.008
  11. Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development. Cancer Epidemiol Biomarkers Prev. 2002 Nov; 11(11):1316-21.
    View in: PubMed
    Score: 0.007
  12. Differential effect of an anti-CD8 monoclonal antibody on rejection of murine intestine and cardiac allografts. Transplant Proc. 1999 Feb-Mar; 31(1-2):1239-41.
    View in: PubMed
    Score: 0.006
  13. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice. Transplantation. 1999 Jan 15; 67(1):131-7.
    View in: PubMed
    Score: 0.006
  14. Ploidy as a prognostic feature in colonic adenocarcinoma. Arch Surg. 1996 Jun; 131(6):587-92.
    View in: PubMed
    Score: 0.005
  15. Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. Transplantation. 1996 May 15; 61(9):1365-9.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.